Influence of protein binding on acrolein turnover in vitro by oxazaphosphorines and liver microsomes
- PMID: 15900571
- PMCID: PMC6808015
- DOI: 10.1002/jcla.20062
Influence of protein binding on acrolein turnover in vitro by oxazaphosphorines and liver microsomes
Abstract
For a correct determination of acrolein amounts generated in in vitro turnover experiments with oxazaphosphorines, it is necessary to characterize the interaction of acrolein with liver microsomal proteins. Acrolein, a highly reactive metabolite of oxazaphosphorines, readily forms covalent adducts with proteins by electrophilic attack on nucleophiles, such as the sulfhydryl group of cysteine, imidazole group of histidine, and amino group of lysine. The current investigations were mainly directed toward determination of the degree of acrolein-protein binding under conditions of in vitro experiments with liver microsome preparations. The acrolein concentration in protein dilution was determined by a fluorescence method. Moreover, the influence of sucrose and glycerine on the extent of acrolein-protein binding commonly used for the stabilization of microsomal preparations during storage was investigated. The current investigations show evidence that the chemical reaction of acrolein with liver microsomal proteins strictly follows first order kinetics. The main part of the formed acrolein in the in vitro attempts is available as bound part. Results of these investigations indicate that the calibration should be carried out with mixtures from liver microsome preparations and known amounts of acrolein under the same conditions as the in vitro experiments to record the entirely formed acrolein part (free and bound) in oxazaphosphorine turnover experiments. Glycerine is recommended as a preservative to store liver microsomes instead of sucrose because the latter reacts with acrolein.
Copyright 2005 Wiley-Liss, Inc.
Similar articles
-
Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.Cancer Res. 1984 Oct;44(10):4615-21. Cancer Res. 1984. PMID: 6380709
-
Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.J Biol Chem. 1981 Nov 25;256(22):11691-701. J Biol Chem. 1981. PMID: 7298626
-
Interaction of cyclophosphamide metabolites with membrane proteins: an in vitro study with rabbit liver microsomes and human red blood cells. Effect of thiols.Biochem Pharmacol. 1982 Nov 15;31(22):3535-41. doi: 10.1016/0006-2952(82)90572-x. Biochem Pharmacol. 1982. PMID: 7181935
-
Oxazaphosphorines: new therapeutic strategies for an old class of drugs.Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):919-38. doi: 10.1517/17425255.2010.487861. Expert Opin Drug Metab Toxicol. 2010. PMID: 20446865 Review.
-
Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease.Mol Nutr Food Res. 2008 Jan;52(1):7-25. doi: 10.1002/mnfr.200700412. Mol Nutr Food Res. 2008. PMID: 18203133 Free PMC article. Review.
Cited by
-
Acrolein: unwanted side product or contribution to antiangiogenic properties of metronomic cyclophosphamide therapy?J Cell Mol Med. 2008 Dec;12(6B):2704-16. doi: 10.1111/j.1582-4934.2008.00255.x. Epub 2008 Feb 4. J Cell Mol Med. 2008. PMID: 18266977 Free PMC article.
References
-
- Marinello AJ, Bansal SK, Paul B, et al. 1984. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P‐450. Cancer Res 44:4615–4621. - PubMed
-
- Kanekal S, Kehrer JP. 1993. Evidence for peroxidase‐mediated metabolism of cyclophosphamide. Drug Metab Dispos 21:37–42. - PubMed
-
- Gurtoo HL, Marinello AJ, Struck RF, Paul B, Dahms RP. 1981. Studies on the mechanism of denaturation of cytochrome P‐450 by cyclophosphamide and its metabolites. J Biol Chem 256:11691–11701. - PubMed
-
- Calingasan NY, Uchida K, Gibson GE. 1999. Protein‐bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72:751–756. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources